Evaluating the clinical effectiveness of new beta-lactam/beta-lactamase inhibitor combination antibiotics: A systematic literature review and meta-analysis

• Main Authors: Geneva M. Wilson (Author), Margaret A. Fitzpatrick (Author), Kyle Walding (Author), Beverly Gonzalez (Author), Marin L. Schweizer (Author), Katie J. Suda (Author), Charlesnika T. Evans (Author)
• Format: Book
• Published: Cambridge University Press, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background: Ceftazidime/avibactam (C/A), ceftolozane/tazobactam (C/T), imipenem/relebactam (I/R), and meropenem/vaborbactam (M/V) combine either a cephalosporin (C/T and C/A) or a carbapenem antibiotic (M/V and I/R) with a β-lactamase inhibitor. They are used to treat carbapenem-resistant E...